Xiamen Juda Chemical & Equipment Co., Ltd. is one of the leading manufacturers and suppliers of pharmaceutical-grade hfa 152a: the future-compliant medical propellant in China. If you are looking for pharmaceutical-grade hfa 152a: the future-compliant medical propellant, please be free to buy our quality products at competitive price from our factory. Contact us for quotation.
Pharmaceutical-Grade HFA 152a: The Future-Compliant Medical Propellant Tel：+86-592-5803997
HFA 152A (1,1-difluoroethane) represents the next generation of medical aerosol propellants, engineered for the evolving regulatory and environmental landscape. As the leading low GWP aerosol propellant alternative to HFA-134a and HFA-227ea, it offers pharmaceutical OEMs and formulation scientists a strategic pathway to sustainable, future-compliant Metered-Dose Inhaler (pMDI) platforms. With a Global Warming Potential (GWP) of 124-over 90% lower than legacy options-this HFA 152a medical propellant directly addresses the economic and compliance pressures of global phasedown schedules like the Kigali Amendment.
Technical Specifications & GWP Advantage
The core technical parameters of our pharmaceutical-grade HFA 152a medical propellant are detailed below.
| Property | Specification / Value | Notes / Comparison |
|---|---|---|
| Chemical Name | 1,1-Difluoroethane | - |
| Chemical Formula | CH₃CHF₂ | - |
| Boiling Point | -23.8°C | Provides a high vapor pressure, suitable for aerosol products requiring higher spray speed. |
| Vapor Pressure | High | Optimal for rapid and consistent actuator performance. |
| Global Warming Potential (GWP) | 124 | 100-year timescale relative to CO₂. Significantly lower environmental GWP than alternatives. |
| GWP Comparison | HFA-134a: 1,430 HFA-227ea: 3,220 HFA-152A: 124 |
Quantifies the primary environmental performance advantage and carbon cost avoidance. |
| Regulatory Status | Compliant with Kigali Amendment | Positions product to avoid future carbon tax costs (e.g., EU carbon tax ~€100/tonne CO₂e). |
HFA 152A for Pharmaceutical MDI Formulation: A Technical & Regulatory Guide Tel：+86-592-5803997
This low GWP aerosol propellant is more than a direct replacement; it is a key component for next-generation inhaler design.
Formulation Performance: With a boiling point approximately -29.8°C, HFA 152A is more volatile than HFA-134a (-26.1°C), enabling faster container evacuation and efficient dose delivery. This property is particularly advantageous for oral sprays and specific pMDI formulations requiring precise spray dynamics.
Regulatory Pathway: Adopting HFA-152A is a proactive strategy for Kigali Amendment compliance. Its low GWP future-proofs your product portfolio against stringent HFC phasedown regulations and associated financial burdens, providing a clear long-term alternative to HFA 134A and HFA 227EA.
B2B Procurement: From Development Samples to Bulk Supply Tel：+86-592-5803997
We are a specialized medical propellant supplier structured to support the stringent requirements of the global pharmaceutical industry. We facilitate every stage, from early-stage R&D to commercial-scale manufacturing.
Scalable, cGMP-Aligned Packaging: Available in industry-standard, clean 22.2lb/10.1kg disposable cylinders for laboratory and pilot-scale work, progressing to 926L ton cylinders and 22-ton ISOTANK shipments for full-scale production, ensuring a secure and efficient supply chain.
Full Regulatory & Quality Documentation: As a trusted partner for OEM aerosol propellant supply, we provide comprehensive support for your regulatory filings. Our products are backed by a Drug Master File (DMF) and manufactured under a certified quality management system (ISO, OHSAS), guaranteeing the high quality and batch-to-batch consistency required for pharmaceutical applications.
Technical Partnership: Our 20 years of experience in fluorine chemical export includes dedicated R&D support. We collaborate on OEM/ODM projects, offering expertise in propellant behavior and compatibility to accelerate your HFA 152a vs HFA 134a MDI transition and formulation optimization.
Factory Tour Tel：+86-592-5803997
Company Profile Tel：+86-592-5803997
Xiamen Juda Chemial & Equipment Co. Ltd, established in 1988, was a subsidiary of China's chemical manufacturing pioneer called Juhua Group Corporation. Xiamen Juda has been focusing on fluorinated chemicals export since year 2004. As one of the earliest exporters of refrigerants in China, we have a complete range of various refrigerants and other fluorinated chemicals. 35 years' development and quality certification have been ensuring our quality supply and service to our long term business partners from all over the world in 7 major product series:Refrigerant Gas,Medical Aerosol Propellant,Cleaning Agent,Fire Extinguishing Agent,Welding Gas,Cooling Fluids,
Fluoropolymer.
Our chemicals and packaging have been in certified level of : FDA DMF, UL, CE,DOT, KGS, ASME, ISO,OHSAS.
Packing Tel：+86-592-5803997
30lb/13.6kg Disposable cylinder
926L Ton Cylinder
22 Ton ISOTANK
why choose us!
Years in industry
20 years experience in fluorine chemical and euiqment export
Quick response
Any inquiries will be replied within 12 hours.
high quality
Finished product inspection.
OEM/ODM Available.
Welcome to contact us for more product details.
FAQ: Key Considerations for B2B Buyers
Q: Is HFA-152A accepted for use in pharmaceutical products?
A: Yes, HFA-152A is a recognized hydrofluoroalkane (HFA) propellant developed as an environmentally preferable alternative to CFCs and higher-GWP HFAs. It is suitable for medical aerosol products including pMDI inhalers. Its adoption is supported by a regulatory strategy aligned with global environmental treaties.
Q: What specific documentation do you provide to support regulatory filings?
A: We provide a complete pharmaceutical data package, which can include access to our Drug Master File (DMF), Certificate of Analysis for each batch, and detailed safety and handling data (SDS). This is part of our commitment to quality guarantee and partnership.
Q: Can you supply small quantities for formulation development and testing?
A: Absolutely. We support R&D efforts by supplying product in appropriate packaging, such as smaller cylinders, to enable feasibility studies, compatibility testing, and actuator performance trials for propellant for pMDI inhalers.
Hot Tags: pharmaceutical-grade hfa 152a: the future-compliant medical propellant, suppliers, manufacturers, factory, quotation, price, buy, HFA Propellant R134a, Propellant Gas
